Abstract Severe Acute Respiratory Syndrome–Coronavirus-2 is responsible for the current
pandemic that has led to more than 10 million confirmed cases of Coronavirus Disease-19 …

Venous thromboembolism, comprising both deep vein thrombosis and pulmonary embolism,
is a chronic illness that affects nearly 10 million people every year worldwide. Strong …

Background Clinical trials and meta-analyses have suggested that aspirin may be effective
for the prevention of venous thromboembolism (proximal deep-vein thrombosis or …

This is a recommended evaluation and management algorithm from the Western Trauma
Association (WTA) Algorithms Committee focused on the management of pharmacologic …

Background Accumulated evidence supports the existence of sex-associated differences in
immune systems. Understanding the role of sex in immune-related adverse events (irAEs) is …

Patients undergoing total hip and knee arthroplasty are at high risk for venous
thromboembolism (VTE) with an incidence of approximately 0.6–1.5%. Given the high …

Written by a leading expert on Aspirin-related research, this is the most comprehensive
treatise on the pharmacological effects and clinical applications of one of the most …

Venous thromboembolism (VTE) is a major issue in trauma patients. Without prophylaxis,
the rate of deep venous thrombosis approaches 60% and even with chemoprophylaxis may …

Importance The optimal pharmacologic thromboprophylaxis agent after total hip and total
knee arthroplasty is uncertain and consensus is lacking. Quantifying the risk of postoperative …

Rationales and uncertainties for aspirin use in COVID-19: a narrative review - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …